Suppr超能文献

在滴注过程中,一种冻干单克隆抗体制剂的蛋白亚可见颗粒和自由基形成。

Protein Sub-Visible Particle and Free Radical formation of a Freeze-Dried Monoclonal Antibody Formulation During Dropping.

机构信息

Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058 China; Hangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou, 310016 China.

Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058 China; Hangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou, 310016 China.

出版信息

J Pharm Sci. 2021 Apr;110(4):1625-1634. doi: 10.1016/j.xphs.2020.10.008. Epub 2020 Oct 10.

Abstract

Dropping during shipping and handling of liquid biopharmaceutical formulations has long been known to cause protein degradation and aggregation. On the other hand, accidental dropping of freeze-dried protein formulations is generally considered not a major issue for biopharmaceutical quality. Reports of stability and especially the underling degradation mechanism(s) during shipping and handling of freeze-dried protein formulations were rarely seen in literature. In this manuscript, we report an interesting phenomenon in which repeated dropping of freeze-dried monoclonal antibody X (mAb-X) formulation powder resulted in significant protein sub-visible particles (SbVPs) in the reconstituted liquid as determined by the sensitive particle analyzing technique micro-flow imaging (MFI). Free radicals were observed after repeated dropping by electron paramagnetic resonance (EPR). Formation of SbVPs could be partially inhibited by the free radical scavengers methionine and 3-carbamoyl-2,2,5,5-tetramethyl-1-pyrrolidin-yloxy free radical (CTPO). The amount of free radicals and SbVPs was correlated to the sample temperature during dropping. Therefore we propose that the high temperature formed during dropping was probably the root cause for protein aggregation and free radical formation, which could further cause protein aggregation. Our observations suggest that similar to liquid protein formulations, dropping of freeze-dried protein formulations should also be avoided or mitigated.

摘要

在液体生物制药制剂的运输和处理过程中,经常会出现药物下降的情况,这会导致蛋白质降解和聚集。另一方面,冻干蛋白质制剂的意外下降通常被认为不会对生物制药质量产生重大影响。在文献中很少有关于在运输和处理冻干蛋白质制剂过程中的稳定性,尤其是潜在降解机制的报告。在本文中,我们报告了一个有趣的现象,即反复下降冻干单克隆抗体 X(mAb-X)制剂粉末会导致再配制的液体中出现明显的蛋白质亚可见颗粒(SbVP),这是通过灵敏的颗粒分析技术微流成像(MFI)来确定的。在反复下降后,通过电子顺磁共振(EPR)观察到自由基。自由基清除剂蛋氨酸和 3-氨甲酰基-2,2,5,5-四甲基-1-吡咯啉-yloxy 自由基(CTPO)可以部分抑制 SbVP 的形成。自由基和 SbVP 的数量与下降过程中的样品温度有关。因此,我们提出在下降过程中形成的高温可能是蛋白质聚集和自由基形成的根本原因,这可能会进一步导致蛋白质聚集。我们的观察结果表明,类似于液体蛋白质制剂,冻干蛋白质制剂的下降也应避免或减轻。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验